PFG Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.38M Sell
4,488
-105
-2% -$107K 0.27% 81
2026
Q1
$4.22M Buy
4,593
+586
+15% +$594K 0.21% 122
2025
Q4
$4.31M Sell
4,007
-3,261
-45% -$3.12M 0.21% 110
2025
Q3
$5.55M Sell
7,268
-19,720
-73% -$14.7M 0.23% 111
2025
Q2
$3.96M Buy
26,988
+22,888
+558% +$17.8M 0.18% 118
2025
Q1
$3.39M Buy
4,100
+468
+13% +$389K 0.19% 136
2024
Q4
$2.8M Buy
3,632
+215
+6% +$178K 0.17% 144
2024
Q3
$3.03M Buy
3,417
+53
+2% +$47.6K 0.19% 125
2024
Q2
$3.05M Buy
3,364
+396
+13% +$317K 0.21% 125
2024
Q1
$2.31M Buy
2,968
+954
+47% +$679K 0.17% 151
2023
Q4
$1.17M Sell
2,014
-4
-0.2% -$2.33K 0.09% 241
2023
Q3
$1.08M Sell
2,018
-2,678
-57% -$1.38M 0.1% 236
2023
Q2
$2.2M Buy
4,696
+1,537
+49% +$645K 0.17% 155
2023
Q1
$1.08M Buy
3,159
+1,946
+160% +$656K 0.09% 263
2022
Q4
$444K Buy
1,213
+53
+5% +$18.8K 0.04% 372
2022
Q3
$375K Sell
1,160
-64
-5% -$20.3K 0.04% 372
2022
Q2
$397K Buy
1,224
+132
+12% +$39.6K 0.04% 276
2022
Q1
$313K Sell
1,092
-10
-0.9% -$2.57K 0.03% 331
2021
Q4
$304K Hold
1,102
0.03% 440
2021
Q3
$255K Sell
1,102
-200
-15% -$49.4K 0.03% 444
2021
Q2
$299K Sell
1,302
-17
-1% -$3.42K 0.03% 391
2021
Q1
$246K Buy
+1,319
New +$258K 0.03% 399

Other funds holding LLY

PFG Advisors's LLY Position: Q2 2026 in Review

PFG Advisors reduced its Eli Lilly (LLY) stake by 2.3% in Q2 2026, selling an estimated $107K and leaving 4,488 shares worth $5.38M. The position accounts for 0.27% of the portfolio, ranked #81.

PFG Advisors first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.55M in Q3 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PFG Advisors held 4,488 shares of Eli Lilly worth $5.38M as of Q2 2026.
  • PFG Advisors sold 105 Eli Lilly shares in Q2 2026, an estimated $107K.
  • Eli Lilly made up 0.27% of PFG Advisors's portfolio in Q2 2026, its #81 holding.
  • PFG Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • PFG Advisors's Eli Lilly position peaked at $5.55M in Q3 2025.
  • 1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PFG Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.